Tag: Roots Analysis
The opportunity for AR / VR based digital marketing service
Over time, various pharma players have taken advantage of these immersive technologies for education, training as well as marketing, purposes. These technologies have been demonstrated to be capable of driving better customer engagement, and generating us...
The continuous manufacturing market - Rootsanalysis
Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing
The global handheld ultrasound imaging devices market is projected
The increasing medical diagnostic imaging burden has compelled industry players to develop advanced handheld ultrasound scanners that will enable physicians to accurately visualize all major organ systems for diagnostic purposes
The contract manufacturing market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030, predicts Roots Analysis
Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world
The Companion Diagnostics Development Services Market
In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise
The nuclear medicine and radiopharmaceutical manufacturing
The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufacture nuclear medicine and radiopharm...
The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis
Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillar...
The “Encapsulated Cell Therapies and Encapsulation Technologies Market”
? A detailed assessment of the current market landscape of encapsulated cell therapies and affiliated technologies, highlighting various target disease indications, phase of development, encapsulation method, type of cells / API, and route of administrati...
The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis
Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages
The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, and is projected to be worth around USD 14 Billion in 2030, claims Roots Analysis
Roots Analysis has announced the addition of “CAR-T Cell Therapies Market (3rd Edition) by Target Indications
The modular facilities market is estimated to be worth USD 6.4 billion in 2030, predicts Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “Modular Facilities in Pharmaceutical and Biotechnology Market”
Roots Analysis'The virtual clinical trial service providers market is projected to grow at an annualized rate of ~14%- Roots Analysis'
Roots Analysis has done a detailed study on Virtual Clinical Trial Service Providers Market, 2020-2050, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
The virtual clinical trial service providers market is estimated to be worth USD 12 billion in 2050- Roots Analysis'
Conventional clinical trials are fraught with inefficient patient management and data handling practices, which has prompted trial sponsors to implement digital innovation and virtual technologies across different aspects of drug development.
The gene therapy market is projected to be growing at a CAGR of 30%- Roots Analysis'
Given their potential to treat rare, inherited diseases, as well as those previously deemed incurable, the field of gene therapy has gained significant traction in the last few years
The gene therapy market is projected to be worth USD 14.6 billion in 2030- Roots Analysis'
Driven by the potential to treat the root cause of diseases, including rare clinical conditions and those that were previously deemed incurable, the gene therapies pipeline is growing, and the market anticipated to witness substantial growth, till 2030
